Caffeine treatment of ovine cytoplasts regulates gene expression and foetal development of embryos produced by somatic cell nuclear transfer

2010 ◽  
Vol 77 (10) ◽  
pp. 876-887 ◽  
Author(s):  
Inchul Choi ◽  
Joon-Hee Lee ◽  
Pat Fisher ◽  
Keith H.S. Campbell
Keyword(s):  
Gene Expression ◽  
Somatic Cell ◽  
Somatic Cell Nuclear Transfer ◽  
Nuclear Transfer ◽  
Foetal Development ◽  
Caffeine Treatment

64 X-LINKED GENE EXPRESSION IN BOVINE (BOS TAURUS) MALE AND FEMALE IN VITRO- FERTILIZED AND SOMATIC CELL NUCLEAR TRANSFER-DERIVED BLASTOCYSTS

2006 ◽  
Vol 18 (2) ◽  
pp. 140
Author(s):  
M. Nino-Soto ◽  
G. Mastromonaco ◽  
P. Blondin ◽  
W. A. King
Keyword(s):  
Gene Expression ◽  
Developmental Stage ◽  
Somatic Cell ◽  
Dosage Compensation ◽  
Somatic Cell Nuclear Transfer ◽  
Nuclear Transfer ◽  
Regulatory Mechanisms ◽  
Linked Gene ◽  
Male And Female

Expression of some X-chromosome linked genes has recently been shown to be altered in bovine somatic cell nuclear transfer (SCNT) derived embryos (Wrenzycki et al. 2002 Biol. Reprod. 66, 127), implying that the regulatory mechanisms of X-linked transcription are affected by embryo in vitro production (IVP) methods. We analyzed the transcriptional pattern of X-linked genes (BIRC4, GAB3, HPRT1, MECP2, RPS4X, SLC25A6, and XIST) in bovine in vitro fertilized (IVF) and SCNT male and female blastocysts to determine X-inactivation status and changes resulting from IVP. We collected pools of male (n = 5 pools) and female (n = 3 pools) IVF-derived blastocysts (Bousquet et al. 1999 Theriogenology 51, 59) and male (n = 5 pools) and female (n = 3 pools) SCNT-derived blastocysts (Mastromonaco et al. 2004 Reprod. Domest. Anim. 39, 462). Each pool consisted of five blastocysts. Embryos were washed in phosphate buffered saline (PBS) + 0.1% polyvinyl alcohol (PVA), collected, and stored at -80�C. Total RNA was extracted with an Absolutely RNA Microprep kit (Stratagene, La Jolla, CA, USA), DNase I treated, and precipitated with isopropanol and linear acrylamide (Ambion, Inc., Austin, TX, USA) as a carrier. Reverse transcription was performed with Oligo-dT (Invitrogen, Burlington, Ontario, Canada) and Superscript II RT (Invitrogen). Transcript quantification was performed by quantitative real-time PCR using SYBR Green I (LightCycler system, Roche, Diagnostics, Laval, Quebec, Canada). Data analysis was performed with SAS (SAS Institute, Inc., Cary, SC, USA) using a mixed-model factorial ANOVA and with results presented as estimates of the median, ratios of estimates, and 95% confidence intervals with � = 0.05. IVF-derived male and female blastocysts possessed similar levels of the transcripts analyzed, suggesting successful dosage compensation at this developmental stage for embryos fertilized in vitro. XIST was not detected in male IVF embryos. GAB3 was not detected in any of the female groups and, in addition, HPRT1 transcripts were not detected in SCNT derived female embryos. Male and female SCNT-derived blastocysts possessed marked differences in their transcript levels, with males showing statistically significantly higher levels of BIRC4 and RPS4X and females possessing higher levels of MECP2 and SLC25A6 transcripts although differences between the latter two were not statistically significant. XIST was detected in both male and female SCNT blastocysts. We conclude that dosage compensation between male and female IVF blastocysts is achieved at this developmental stage for the transcripts examined. However, this pattern was markedly changed in the SCNT group, affecting especially female SCNT blastocysts, suggesting that the regulatory mechanisms of X-inactivation and X-linked gene expression are substantially altered in SCNT embryos probably due to aberrant epigenetic patterns and faulty genome reprogramming. We are currently analyzing X-linked transcription in male and female in vivo-derived blastocysts in order to compare this group with IVP-derived embryos. This work was funded by NSERC, CIHR, and CRC.

scholarly journals Epigenetic reprogramming in embryonic and foetal development upon somatic cell nuclear transfer cloning

Reproduction ◽  
2008 ◽  
Vol 135 (2) ◽  
pp. 151-163 ◽  
Author(s):  
Heiner Niemann ◽  
X Cindy Tian ◽  
W Allan King ◽  
Rita S F Lee
Keyword(s):  
Somatic Cell ◽  
Cell Nucleus ◽  
Somatic Cell Nuclear Transfer ◽  
Nuclear Transfer ◽  
Donor Cell ◽  
Epigenetic Reprogramming ◽  
Biological Research ◽  
Foetal Development ◽  
Research Activities ◽  
Somatic Cell Nucleus

The birth of ‘Dolly’, the first mammal cloned from an adult donor cell, has sparked a flurry of research activities to improve cloning technology and to understand the underlying mechanism of epigenetic reprogramming of the transferred somatic cell nucleus. Especially in ruminants, somatic cell nuclear transfer (SCNT) is frequently associated with pathological changes in the foetal and placental phenotype and has significant consequences for development both before and after birth. The most critical factor is epigenetic reprogramming of the transferred somatic cell nucleus from its differentiated status into the totipotent state of the early embryo. This involves an erasure of the gene expression program of the respective donor cell and the establishment of the well-orchestrated sequence of expression of an estimated number of 10 000–12 000 genes regulating embryonic and foetal development. The following article reviews the present knowledge on the epigenetic reprogramming of the transferred somatic cell nucleus, with emphasis on DNA methylation, imprinting, X-chromosome inactivation and telomere length restoration in bovine development. Additionally, we briefly discuss other approaches towards epigenetic nuclear reprogramming, including the fusion of somatic and embryonic stem cells and the overexpression of genes crucial in the formation and maintenance of the pluripotent status. Improvements in our understanding of this dramatic epigenetic reprogramming event will be instrumental in realising the great potential of SCNT for basic biological research and for various agricultural and biomedical applications.

28 TREATMENT WITH SUBEROYLANILIDE HYDOXAMIC ACID OR SODIUM BUTYRATE ON PORCINE SOMATIC CELL NUCLEAR TRANSFER EMBRYOS DERIVED FROM KIDNEY CELLS OF HUMAN HEME OXYGENASE-1 TRANSGENIC PIG

2014 ◽  
Vol 26 (1) ◽  
pp. 128
Author(s):  
K.-Y. Song ◽  
J.-H. Moon ◽  
E.-J. Park ◽  
S.-J. Kim ◽  
Y.-B. Choi ◽  
...  
Keyword(s):  
Gene Expression ◽  
Somatic Cell ◽  
Sodium Butyrate ◽  
Somatic Cell Nuclear Transfer ◽  
Nuclear Transfer ◽  
Total Cell ◽  
Heme Oxygenase 1 ◽  
Kidney Cells ◽  
Cloning Efficiency ◽  
Blastocyst Formation

Because somatic cell nuclear transfer (SCNT) is influenced by many factors concerning a series of various steps, the cloning efficiency is low in so many species and it seems to be more serious in production of transgenic (TG) animals. Reprogramming of donor nucleus is one of the important factors that affects the developmental competence of SCNT embryos, and several epigenetic remodelling drugs have been used to improve the cloning efficiency. In this study, we examined the effect of suberoylanilide hydoxamic acid (SAHA) or sodium butyrate (NaBu) treatment on the development of porcine SCNT embryos derived from kidney cells of TG pig. Fully confluent porcine kidney cells expressing the human heme oxigenase-1 gene were used for nuclear donor. For SCNT, matured oocytes with 1st polar body were enucleated, electrically fused, and activated 1 h after fusion (Song et al. 2009 Mol. Reprod. Dev. 76, 611–619). Then, SCNT embryos were incubated in postactivation medium [PA; porcine zygote medium-5 (PZM-5) supplemented with 0.5% dimethyl sulfoxide] for 4 h (control), PA with 0.4 μg mL–1 demecolcine for 4 h (Dc), PA with 0.5 μM SAHA for 9 h (SAHA), or PA with 1 mM NaBu for 9 h (NaBu). After postactivation treatment, SCNT embryos were cultured in fresh PZM-5 for 7 days. The embryos were examined for cleavage and blastocyst formation on Days 2 and 7, respectively (the day of SCNT was designated Day 0). Total cell number of blastocysts was examined by counting the number of nuclei stained with Hoechst 33342 under ultraviolet light. Complementary DNA synthesised with total RNA extracted from blastocysts were used for qRT-PCR to determine HDAC2, HDAC6, and GAPDH gene expression. Data were analysed by one-way ANOVA followed by Tukey's multiple comparison test using GraphPad Prism version 5.01 (Graphpad Software, San Diego, CA, USA). The cleavage rates (77.0–82.9%) of treated embryos were not different from that of control embryos (79.0%). Blastocyst formation was slightly increased in Dc- (36/132, 27.3%), SAHA- (34/125, 28.6%), and NaBu- (36/133, 27.3%) treated embryos than in control embryos (32/128; 25.0%), but the difference was not significant. Total cell numbers (45.2–47.5) of treated embryos were not different from that of control embryos (51.8). Expression of HDAC2 was higher in SAHA-treated embryos than in control and Dc-treated embryos (P < 0.05), but it was not different from that of NaBu-treated embryos. The relative expression of HDAC6 transcript was increased in SAHA- and NaBu-treated embryos, but there was no significant difference among all groups. Although SAHA or NaBu did not improve the pre-implantational development of porcine SCNT embryos derived from kidney cells of TG pig as assessed in this study, additional studies are needed to determine the effect of SAHA or NaBu on gene expression of pig TG embryos and developmental competency following embryo transfer according to the origin of donor cells. This study was supported by IPET (#311011-05-2-SB010), MOTIE (#10033839-2012-21) and the TS Corporation.

Sign in / Sign up

Export Citation Format

Share Document